Many people suffer from diabetes, and among those who suffer from this disease are identified under type 2 diabetes. Fortunately, there is a way to put this into remission, and it all starts with a diet.
Diabetes is, simply put, what results from having high blood sugar and low insulin levels. If left untreated, it may lead to serious and even fatal complications such as a heart attack or a stroke. By going on a healthy diet and enough exercise, blood sugar levels can be controlled along with insulin levels and diabetes can be placed into remission. Express reports that along with cutting back on sugar, yogurt can be included in a diet for those suffering from type 2 diabetes.
As to why yogurt is something that can be incorporated into a type 2 diabetes-friendly diet, nutritionists say that yogurt is a very good source of calcium, vitamin d, potassium, and protein. Yogurt also helps aid in the protection of bones as well as teeth. Because yogurt has probiotics or the good kind of bacteria, it also helps reduce inflammation as those with type 2 diabetes tend to have high inflammation levels in the body.
However, not every yogurt in the market is made the same way. There are still kinds of yogurt to avoid. Sometimes the yogurt being sold in the market is not as healthy as it may seem to be. Some yogurts have more of the good bacteria than others, it will all depend on the brand.
The kind of yogurt that is advisable for those suffering from type 2 diabetes is probiotic yogurt. This because probiotic yogurt has active, live cultures.
A study was conducted by the US National Library of Medicine Institutes of Health on the consumption of probiotic yogurt and the effect it has on a person’s blood sugar. The participants of the study had their blood sugar levels taken before and after. They found that those who consumed probiotic yogurt every day had lower blood sugar levels.
When it all comes down to it, people with type 2 diabetes should opt for unflavored and fat-free or at least probiotic yogurt that is also low-fat.


Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Moderna to Pay Up to $2.25B to Settle LNP Patent Dispute Over COVID-19 Vaccine Technology
Novo Nordisk Warns of Profit Decline as Wegovy Faces U.S. Price Pressure and Rising Competition
FDA Warns Novo Nordisk Over Misleading Ozempic Ad Claims
Federal Appeals Court Blocks Trump-Era Hospital Drug Rebate Plan
RFK Jr. Overhauls Federal Autism Panel, Sparking Medical Community Backlash
Moderna Stock Drops After FDA Declines Review of mRNA Flu Vaccine
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
U.S. Officials Express Optimism Over New CDC Director Selection Amid Vaccine Policy Turmoil
Merck Raises Growth Outlook, Targets $70 Billion Revenue From New Drugs by Mid-2030s
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Novartis’ Vanrafia Shows Strong Phase 3 Results in IgA Nephropathy, Paving Way for Full Approval 



